BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (“Butterfly”) (NYSE: BFLY), a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, provided a business update today at the 42nd Annual J.P. Morgan Healthcare Conference. A webcast replay of the conference presentation can be viewed here, and will be available until February 10th, 2024. The presentation slide deck with animated videos can be accessed here ...

8 Changes in Internal Control over Financial Reporting We are currently and may in the future be subject to legal proceedings, claims, and regulatory actions arising in the ordinary course of business. The outcome of any such matters, regardless of the merits, is inherently uncertain. Item 2. Unregistered Sales of Equity Securities and Use of Proceeds We did not repurchase any of our equity securities during the three months ended September 30, 2023. Item 5. Other Information See Exhibit Index. EXHIBIT INDE ...

Butterfly Network, Inc. (NYSE:BFLY) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Heather Getz - Chief Financial and Operations Officer Joseph DeVivo - Chairman & Chief Executive Officer Conference Call Participants Joshua Jennings - TD Cowen Suraj Kalia - Oppenheimer Operator Hello. Thank you for attending the Butterfly Network Q3 2023 Earnings Call. My name is Victoria, and I'll be your moderator today. All lines will be muted during the presentation portion of the call ...

Butterfly Network, Inc. (NYSE:BFLY) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants Heather Getz - Executive Vice President & Chief Financial Officer Joseph DeVivo - Chairman & Chief Executive Officer Conference Call Participants Suraj Kalia - Oppenheimer & Co. Neil Chatterji - B. Riley Securities Joshua Jennings - Cowen Danielle Antalffy - UBS Operator Ladies and gentlemen, hello, and welcome to the Butterfly Network Q2 2023 Earnings Call. My name is Maxine, and I'll be coor ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Butterfly Network, Inc. (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | |---------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------|-------------------------------------------------------------- ...

Butterfly Network, Inc. (NYSE:BFLY) Q1 2023 Earnings Conference Call May 11, 2023 8:30 AM ET Company Participants Heather Getz - Executive Vice President, Chief Financial Officer Joseph DeVivo - Chairman and CEO Darius Shahida - Chief Strategy Officer Conference Call Participants Joshua Jennings - Cowen Suraj Kalia - Oppenheimer & Co. Neil Chatterji - B. Riley Securities Danielle Antalffy - UBS Operator Ladies and gentlemen, hello and welcome to the Butterfly Network, Inc. Q1 2023 Earnings Call. My name is ...

Table of Contents FORM 10-Q Butterfly Network, Inc. (Exact name of registrant as specified in its charter) Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐ Indicate by check mark whether the registrant has ...

Financial Data and Key Metrics Changes - For Q4 2022, revenue was $19 million, consistent with guidance and a 17% growth year-over-year [64] - Adjusted EBITDA loss improved to $29.3 million from $35.6 million in Q4 2021, driven by increased adjusted gross margin and cost reduction initiatives [44][66] - Adjusted gross profit was $10.3 million, with a margin of 54%, up from 40% in Q4 2021, attributed to a higher proportion of subscription revenues and improved manufacturing productivity [65] Business Line Data and Key Metrics Changes - Product revenue decreased by 12% to $12.7 million due to lower volumes in health systems and e-commerce, partially offset by higher global health volume and average selling prices [64] - Software and services revenue grew by almost 30% to $6.3 million, representing 33% of total revenue, driven by an increased installed base and software renewals [79] Market Data and Key Metrics Changes - The company is focusing on large health systems and hospitals, restructuring its commercial team to enhance efficiency and impact [13][66] - International expansion efforts included partnerships in new markets such as the UAE, India, Israel, and South Africa, unlocking millions of potential customers [39] Company Strategy and Development Direction - The company aims to democratize healthcare by making medical imaging accessible, with a focus on enterprise-wide deployments in health systems [32][34] - The strategy includes leveraging the Butterfly Blueprint software as a "Trojan horse" to facilitate device adoption across health systems [72] - Future plans involve expanding into home use for patient self-scanning and chronic disease monitoring, with ongoing regulatory discussions [61][95] Management's Comments on Operating Environment and Future Outlook - Management noted external resource constraints affecting sales cycles but expects these to alleviate over the year, allowing for improved performance [81] - The company anticipates full-year revenue growth in the high teens to low 20s range, with stronger performance expected in the second half of the year [66] Other Important Information - The company has a strong cash position of $242 million as of December 31, 2022, with a reduced monthly cash burn of $10 million [80] - A search for a full-time CEO is underway, with a focus on finding a leader who can inspire the team and drive the commercial strategy [7][33] Q&A Session Summary Question: What is the pathway for Butterfly iQ device deployments in Blueprint customer accounts? - The deployment of Blueprint allows for entry into large health systems, facilitating the eventual purchase and deployment of Butterfly devices across departments [88][89] Question: What is the current status of the U.S. sales force and enterprise channel leadership? - New commercial leadership has been brought in to focus on U.S. health systems while also finding distribution partners for out-of-hospital settings [91] Question: How is the company progressing towards home imaging and chronic disease management? - The company is working on use cases to ensure regulatory comfort for self-scanning and is making significant progress in image quality and home use capabilities [95][96]

Financial Performance - Total revenue remained flat year-over-year at $19.0 million in Q4 2022[13] - Product revenue decreased by 12% in Q4 2022[13] - Subscription revenue increased by 38% in Q4 2022[13] - Gross profit was $9.6 million with a gross margin of 50.3% in Q4 2022[14] - Adjusted gross profit was $10.3 million with an adjusted gross margin of 54.5% in Q4 2022[14] - Adjusted EBITDA loss was ($29.3) million in Q4 2022[14] - Cash, cash equivalents, and marketable securities totaled $237.8 million[14] Future Outlook - The company anticipates revenue growth in the high teens to low 20 percent range for full year 2023[17] - The company expects an adjusted EBITDA loss between ($95) million and ($85) million for full year 2023[17] Strategic Initiatives - Butterfly aims to democratize healthcare by making medical imaging accessible to everyone[3] - The company is focused on expanding its solution to home healthcare, health systems, international markets, and veterinary medicine[5, 10, 11] - Butterfly is deploying its enterprise platform at scale across key reference sites[9]

1 Q3 2022 Earnings Call November 03, 2022 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. Butterfly Network, Inc.'s (the "Company") actual results may differ from its expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "pr ...